⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30476130 | 0.75 | — | — | |
| SCHEMBL28646765 | 0.72 | — | — | |
| SCHEMBL29061333 | 0.72 | — | — | |
| SCHEMBL29224558 | 0.71 | — | — | |
| SCHEMBL30380526 | 0.64 | — | — | |
| SCHEMBL29203710 | 0.62 | — | — | |
| SCHEMBL22193800 | 0.58 | — | — | |
| SCHEMBL29259049 | 0.56 | — | — | |
| SCHEMBL2374044 | 0.54 | — | — | |
| SCHEMBL6278613 | 0.37 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118119404-A | Immunogenic LNP compositions and methods thereof | 辉瑞公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-113573717-A | RNA editing oligonucleotides and uses thereof | 科罗生物公司 | 2021-10-29 | — | — | CN | disclosed |
| CN-113518623-A | RNA editing oligonucleotides and uses thereof | 科罗生物公司 | 2021-10-19 | — | — | CN | disclosed |
| CN-113453694-A | RNA editing oligonucleotides and uses thereof | 科罗生物公司 | 2021-09-28 | — | — | CN | disclosed |